Maravai LifeSciences Holdings, Inc. Unrealized Gain (Loss) on Derivatives
Maravai LifeSciences Holdings, Inc. (MRVI) reported Unrealized Gain (Loss) on Derivatives of $1.92 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2024-05-09
- Maravai LifeSciences Holdings, Inc. unrealized gain (loss) on derivatives for the quarter ending 2024-03-31 was $1.92M.
- Maravai LifeSciences Holdings, Inc. unrealized gain (loss) on derivatives for the quarter ending 2023-03-31 was -$878.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month |
|---|---|
| 2024-03-31 | $1.92M 10-Q · filed 2024-05-09 |
| 2023-03-31 | -$878.00K 10-Q · filed 2024-05-09 |